共 11 条
- [1] Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease[J] . Robert J Henning.Future Cardiol. . 2016 (0)
- [5] MEDI3617, a human anti-Angiopoietin 2 monoclonal antibody, inhibitsangiogenesis and tumor growth in human tumor xenograft models[J] . Ching Leow,Karen Coffman,Ivan Inigo,Shannon Breen,Meggan Czapiga,Serguei Soukharev,Neill Gingles,Norman Peterson,Christine Fazenbaker,Rob Woods,Bahija Jallal,Sally-Ann Ricketts,Theresa Lavallee,Steve Coats,Yong Chang.International Journal of Oncology . 2012 (5)
- [6] Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (06): : 1991 - 2005
- [7] Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials[J] . Sofoclis Mitsos,Konstantinos Katsanos,Efstratios Koletsis,George C. Kagadis,Nikolaos Anastasiou,Athanasios Diamantopoulos,Dimitris Karnabatidis,Dimitris Dougenis.Angiogenesis . 2012 (1)
- [8] Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles[J] . Robich,Chu,Oyamada,Sodha,Sellke.Expert Review of Cardiovascular Therapy . 2011 (11)
- [10] Plasma Angiopoietin-1, Angiopoietin-2, Angiopoietin Receptor Tie-2, and Vascular Endothelial Growth Factor Levels in Acute Coronary Syndromes[J] . Kaeng W. Lee,Gregory Y.H. Lip,Andrew D. Blann.Circulation . 2004 (16)